Mechanisms of reticulophagy and ER stress mitigation in epidermis

表皮网状吞噬和内质网应激缓解机制

基本信息

  • 批准号:
    10726427
  • 负责人:
  • 金额:
    $ 8.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-15 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract The epidermis forms a multi-layered epithelium that serves as a protective shield for the body, preventing dehydration and pathogen invasion. Its principal cellular constituents, keratinocytes, continually regenerate the cutaneous barrier via a specialized form of differentiation as they move outward in the tissue. At the end of their life in the skin’s outermost layers, keratinocytes initiate a cellular remodeling program called cornification in which they eliminate their organelles to form flattened, keratinized cells. The importance of this process is underscored by many disorders of cornification linked to defective keratinocyte maturation. Despite the advent of biologic treatments for inflammatory skin diseases, development of similar targeted therapies for epidermal barrier dysfunction has been limited by an incomplete understanding of the pathways driving keratinocyte differentiation. The proposed aims address this knowledge gap by applying advanced microscopy, gene editing, and optogenetics to define the mechanisms mediating organelle degradation in human epidermis. This proposal builds on the PI’s K08 project, which found that cornifying keratinocytes induce autophagy, a lysosomal degradation pathway, to break down organelles. The K08-funded work showed that differentiating keratinocytes upregulate an autophagy receptor, NIX, which marked mitochondria and instructed cells in the upper tissue layers to break down these organelles, a step that was essential for epidermal maturation. Our planned experiments will expand the K08 project scope to include the endoplasmic reticulum (ER), testing the hypothesis that keratinocytes utilize distinct autophagy receptors to orchestrate breakdown of the ER (called reticulophagy). Aim 1 will determine how reticulophagy drives programmed ER degradation during cornification and Aim 2 will assess if reticulophagy mitigates damage from ER stress in keratinocytes. Preliminary studies identified candidate receptors that initiate reticulophagy in either a constitutive manner during cornification or upon organelle injury due to ER stress. We will use gain- and loss-of-function approaches in organotypic skin to determine the role of these receptors in directing epidermal morphogenesis and mitigating ER stress. As well, we will leverage live biosensor imaging and optogenetic tools to define how reticulophagy alters signaling mediators that control keratinocyte differentiation, including calcium and reactive oxygen species. Results from the planned work promise to identify novel strategies for normalizing epidermal differentiation in disorders of cornification but also for repairing barrier dysfunction in common diseases like atopic dermatitis and psoriasis. Augmenting the investment by the University of Washington to ensure his success as a physician-scientist, R03 funding will advance the PI’s career development and position him to compete for R01-level funding as he transitions to an independent investigator. The proposed project enhances the PI’s expertise at the intersection of cell biology and dermatology, building an innovative research program that complements his clinical specialty and provides a platform for future translational work to find novel treatments for skin barrier disorders.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cory L Simpson其他文献

Cory L Simpson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cory L Simpson', 18)}}的其他基金

Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    10543010
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    10650345
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    10437615
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    10188438
  • 财政年份:
    2019
  • 资助金额:
    $ 8.83万
  • 项目类别:
Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    9977117
  • 财政年份:
    2019
  • 资助金额:
    $ 8.83万
  • 项目类别:
Role of autophagy in epidermal differentiation and homeostasis
自噬在表皮分化和稳态中的作用
  • 批准号:
    9805013
  • 财政年份:
    2019
  • 资助金额:
    $ 8.83万
  • 项目类别:
Exfoliative toxin A and desmosomal adhesion in epidermis
剥脱性毒素A与表皮桥粒粘附
  • 批准号:
    7485060
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Exfoliative toxin A and desmosomal adhesion in epidermis
剥脱性毒素A与表皮桥粒粘附
  • 批准号:
    7682888
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Exfoliative toxin A and desmosomal adhesion in epidermis
剥脱性毒素A与表皮桥粒粘附
  • 批准号:
    7158275
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
Exfoliative toxin A and desmosomal adhesion in epidermis
剥脱性毒素A与表皮桥粒粘附
  • 批准号:
    7285202
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了